Clinical Trials Directory

Trials / Completed

CompletedNCT02002858

Smoking Cessation for Depression and Anxiety Treatment

Integrated Smoking Cessation Treatment for Emotional Dysregulation

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Houston · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this research study is to enhance smoking cessation outcome among smokers with elevated anxiety and depression. We are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cessation, and anxiety and depression management treatment program (SDAT). Both treatments also utilize nicotine replacement therapy.

Conditions

Interventions

TypeNameDescription
DRUGNicotine Patch
BEHAVIORALDepression and Anxiety Smoking Cessation TreatmentCognitive-behavioral treatment program that blends smoking cessation, anxiety, and depression management/reduction treatment strategies
BEHAVIORALEducational-Support PsychotherapyEducational-based psychotherapy and standard smoking cessation treatment program

Timeline

Start date
2014-10-01
Primary completion
2016-11-01
Completion
2017-05-01
First posted
2013-12-06
Last updated
2017-07-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02002858. Inclusion in this directory is not an endorsement.